2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide

C122H147N23O10 — CID 161037706

IUPAC2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide
SMILESCc1cc(C)c(CNC(=O)c2cc3cc(-c4ccc(N)nc4)cn3c(C(C)N3CCOCC3)c2C)c(=O)[nH]1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4cccnc4)cn3c(C(C)N3CCC(N(C)C)CC3)c2C)c(=O)[nH]1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4ccncc4)cn3c(C(C)N3CCC(N(C)C)CC3)c2C)c(=O)[nH]1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4ccncc4)cn3c(C(C)N3CCOCC3)c2C)c(=O)[nH]1
InChIInChI=1S/2C32H40N6O2.C29H34N6O3.C29H33N5O3/c1-20-15-21(2)35-32(40)29(20)18-34-31(39)28-17-27-16-25(24-7-11-33-12-8-24)19-38(27)30(22(28)3)23(4)37-13-9-26(10-14-37)36(5)6;1-20-14-21(2)35-32(40)29(20)18-34-31(39)28-16-27-15-25(24-8-7-11-33-17-24)19-38(27)30(22(28)3)23(4)37-12-9-26(10-13-37)36(5)6;1-17-11-18(2)33-29(37)25(17)15-32-28(36)24-13-23-12-22(21-5-6-26(30)31-14-21)16-35(23)27(19(24)3)20(4)34-7-9-38-10-8-34;1-18-13-19(2)32-29(36)26(18)16-31-28(35)25-15-24-14-23(22-5-7-30-8-6-22)17-34(24)27(20(25)3)21(4)33-9-11-37-12-10-33/h7-8,11-12,15-17,19,23,26H,9-10,13-14,18H2,1-6H3,(H,34,39)(H,35,40);7-8,11,14-17,19,23,26H,9-10,12-13,18H2,1-6H3,(H,34,39)(H,35,40);5-6,11-14,16,20H,7-10,15H2,1-4H3,(H2,30,31)(H,32,36)(H,33,37);5-8,13-15,17,21H,9-12,16H2,1-4H3,(H,31,35)(H,32,36)
InChIKeyUALXTLNNFIQDAB-UHFFFAOYSA-N
MW2095.67 g/mol
LogP16.72
Rot. Bonds26

About 2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide

2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide (PubChem CID 161037706) has the molecular formula C122H147N23O10 and a molecular weight of 2095.67 g/mol. Its IUPAC name is 2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide.

Molecular Properties

Compound Name2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide
PubChem CID161037706
Molecular FormulaC122H147N23O10
Molecular Weight2095.67 g/mol
Exact Mass2094.17
IUPAC Name2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide
SMILESCc1cc(C)c(CNC(=O)c2cc3cc(-c4ccc(N)nc4)cn3c(C(C)N3CCOCC3)c2C)c(=O)[nH]1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4cccnc4)cn3c(C(C)N3CCC(N(C)C)CC3)c2C)c(=O)[nH]1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4ccncc4)cn3c(C(C)N3CCC(N(C)C)CC3)c2C)c(=O)[nH]1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4ccncc4)cn3c(C(C)N3CCOCC3)c2C)c(=O)[nH]1
InChIInChI=1S/2C32H40N6O2.C29H34N6O3.C29H33N5O3/c1-20-15-21(2)35-32(40)29(20)18-34-31(39)28-17-27-16-25(24-7-11-33-12-8-24)19-38(27)30(22(28)3)23(4)37-13-9-26(10-14-37)36(5)6;1-20-14-21(2)35-32(40)29(20)18-34-31(39)28-16-27-15-25(24-8-7-11-33-17-24)19-38(27)30(22(28)3)23(4)37-12-9-26(10-13-37)36(5)6;1-17-11-18(2)33-29(37)25(17)15-32-28(36)24-13-23-12-22(21-5-6-26(30)31-14-21)16-35(23)27(19(24)3)20(4)34-7-9-38-10-8-34;1-18-13-19(2)32-29(36)26(18)16-31-28(35)25-15-24-14-23(22-5-7-30-8-6-22)17-34(24)27(20(25)3)21(4)33-9-11-37-12-10-33/h7-8,11-12,15-17,19,23,26H,9-10,13-14,18H2,1-6H3,(H,34,39)(H,35,40);7-8,11,14-17,19,23,26H,9-10,12-13,18H2,1-6H3,(H,34,39)(H,35,40);5-6,11-14,16,20H,7-10,15H2,1-4H3,(H2,30,31)(H,32,36)(H,33,37);5-8,13-15,17,21H,9-12,16H2,1-4H3,(H,31,35)(H,32,36)
InChIKeyUALXTLNNFIQDAB-UHFFFAOYSA-N
XLogP16.72
TPSA380.96 Ų
H-Bond Donors9
H-Bond Acceptors25
Rotatable Bonds26
Heavy Atoms155
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002095.67
LogP ≤ 516.72
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1025

Analyze 2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide?
The IUPAC name of 2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide (CID 161037706) is 2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide.
What is the SMILES notation for 2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide?
The canonical SMILES for 2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide is Cc1cc(C)c(CNC(=O)c2cc3cc(-c4ccc(N)nc4)cn3c(C(C)N3CCOCC3)c2C)c(=O)[nH]1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4cccnc4)cn3c(C(C)N3CCC(N(C)C)CC3)c2C)c(=O)[nH]1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4ccncc4)cn3c(C(C)N3CCC(N(C)C)CC3)c2C)c(=O)[nH]1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4ccncc4)cn3c(C(C)N3CCOCC3)c2C)c(=O)[nH]1.
What is the InChIKey of 2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide?
The InChIKey is UALXTLNNFIQDAB-UHFFFAOYSA-N. The full InChI is InChI=1S/2C32H40N6O2.C29H34N6O3.C29H33N5O3/c1-20-15-21(2)35-32(40)29(20)18-34-31(39)28-17-27-16-25(24-7-11-33-12-8-24)19-38(27)30(22(28)3)23(4)37-13-9-26(10-14-37)36(5)6;1-20-14-21(2)35-32(40)29(20)18-34-31(39)28-16-27-15-25(24-8-7-11-33-17-24)19-38(27)30(22(28)3)23(4)37-12-9-26(10-13-37)36(5)6;1-17-11-18(2)33-29(37)25(17)15-32-28(36)24-13-23-12-22(21-5-6-26(30)31-14-21)16-35(23)27(19(24)3)20(4)34-7-9-38-10-8-34;1-18-13-19(2)32-29(36)26(18)16-31-28(35)25-15-24-14-23(22-5-7-30-8-6-22)17-34(24)27(20(25)3)21(4)33-9-11-37-12-10-33/h7-8,11-12,15-17,19,23,26H,9-10,13-14,18H2,1-6H3,(H,34,39)(H,35,40);7-8,11,14-17,19,23,26H,9-10,12-13,18H2,1-6H3,(H,34,39)(H,35,40);5-6,11-14,16,20H,7-10,15H2,1-4H3,(H2,30,31)(H,32,36)(H,33,37);5-8,13-15,17,21H,9-12,16H2,1-4H3,(H,31,35)(H,32,36).
What are the key properties of 2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide?
2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide has a molecular weight of 2095.67 g/mol, XLogP of 16.72, 26 rotatable bonds, 9 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(6-amino-3-pyridinyl)-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-3-ylindolizine-7-carboxamide;5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-pyridin-4-ylindolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-pyridin-4-ylindolizine-7-carboxamide is sourced from PubChem (CID 161037706), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).